600511.SS · 国药股份
China A-shares · RS rating 79 · As of 2026-10-14
| Price | 27.39 CNY |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 79 / 83 / 56 / 64 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 33 / 26 |
| Industry group (rank) | Medical-Hospitals (29) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -2.8% |
| Distance from 52-week high | +10.9% |
| Market cap (USD) | $3.0B |